Huadong Medicine Co., Ltd (SHE:000963)
China · Delayed Price · Currency is CNY 36.28
+0.39 (1.09%)
Feb 3, 2026, 3:04 PM CST
Huadong Medicine Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Net Income | 3,698 | 3,512 | 2,839 | 2,499 | 2,302 | 2,820 |
Depreciation & Amortization | 840.83 | 840.83 | 809.56 | 705.55 | 591.56 | 431 |
Other Amortization | 23.93 | 23.93 | 9.69 | 6.65 | 5.96 | 8.54 |
Loss (Gain) From Sale of Assets | 5.46 | 5.46 | -4.32 | -8.26 | 0.03 | -322.64 |
Asset Writedown & Restructuring Costs | 25.19 | 25.19 | 5.14 | -22.6 | 8.02 | 2.51 |
Loss (Gain) From Sale of Investments | 82.8 | 82.8 | 202.15 | 115.62 | 52.91 | 7.93 |
Provision & Write-off of Bad Debts | 112.18 | 112.18 | 25.76 | 68.69 | 41.69 | 22.83 |
Other Operating Activities | 6.04 | 87.18 | 121.32 | 137.61 | 132.51 | 179.92 |
Change in Accounts Receivable | -1,980 | -1,980 | -968.97 | -2,095 | -775.57 | -530.3 |
Change in Inventory | -498.85 | -498.85 | 213.85 | -491.52 | 18.09 | -37.73 |
Change in Accounts Payable | 1,566 | 1,566 | 685.55 | 1,450 | 770.58 | 797.16 |
Change in Other Net Operating Assets | 20.98 | 20.98 | 43.01 | 7.24 | - | 4.9 |
Operating Cash Flow | 3,853 | 3,749 | 3,929 | 2,382 | 3,170 | 3,411 |
Operating Cash Flow Growth | -7.95% | -4.59% | 64.96% | -24.86% | -7.08% | 70.43% |
Capital Expenditures | -1,883 | -1,728 | -1,607 | -1,193 | -819.1 | -1,473 |
Sale of Property, Plant & Equipment | 27.85 | 19.76 | 10.85 | 15.43 | 79.16 | 373.81 |
Cash Acquisitions | -271.42 | -620.24 | -134.06 | -415.09 | -819.6 | - |
Divestitures | - | - | - | - | -113.37 | - |
Investment in Securities | 212.84 | 112.84 | -115.24 | -948.91 | -357.5 | -629.8 |
Other Investing Activities | 269.35 | 45.23 | 94.52 | 106.2 | 43.72 | -9.66 |
Investing Cash Flow | -1,644 | -2,170 | -1,751 | -2,436 | -1,987 | -1,739 |
Long-Term Debt Issued | - | 5,251 | 4,876 | 4,975 | 2,259 | 2,211 |
Total Debt Issued | 4,227 | 5,251 | 4,876 | 4,975 | 2,259 | 2,211 |
Long-Term Debt Repaid | - | -4,263 | -5,729 | -4,653 | -2,405 | -2,278 |
Total Debt Repaid | -3,975 | -4,263 | -5,729 | -4,653 | -2,405 | -2,278 |
Net Debt Issued (Repaid) | 251.99 | 987.92 | -852.43 | 322.13 | -146.03 | -67.22 |
Issuance of Common Stock | - | - | 10.63 | 104.65 | - | - |
Repurchase of Common Stock | -4.13 | -4.13 | - | - | - | - |
Common Dividends Paid | -1,703 | -1,702 | -594.21 | -576.49 | -460.11 | -565.73 |
Other Financing Activities | -495.88 | -31.28 | 42.66 | 50.01 | -161.31 | -92.78 |
Financing Cash Flow | -1,951 | -749.66 | -1,393 | -99.71 | -767.45 | -725.73 |
Foreign Exchange Rate Adjustments | -75.29 | -47 | 5.95 | -9.77 | 7.11 | -21.44 |
Net Cash Flow | 183 | 781.99 | 791.25 | -163.23 | 422.73 | 925.64 |
Free Cash Flow | 1,971 | 2,021 | 2,323 | 1,189 | 2,351 | 1,938 |
Free Cash Flow Growth | -24.48% | -12.98% | 95.40% | -49.44% | 21.26% | 199.03% |
Free Cash Flow Margin | 4.57% | 4.82% | 5.72% | 3.15% | 6.80% | 5.75% |
Free Cash Flow Per Share | 1.12 | 1.15 | 1.33 | 0.68 | 1.34 | 1.11 |
Cash Interest Paid | - | - | - | 0.62 | 0.95 | - |
Cash Income Tax Paid | 2,879 | 2,563 | 2,552 | 3,018 | 1,539 | 2,165 |
Levered Free Cash Flow | 447.05 | 1,234 | 1,862 | 604.48 | 2,104 | 1,160 |
Unlevered Free Cash Flow | 507.61 | 1,294 | 1,934 | 679.51 | 2,147 | 1,203 |
Change in Working Capital | -940.75 | -940.75 | -78.95 | -1,121 | 35.45 | 261.49 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.